Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.60 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.60 |
| ▸ | FUCA1 | P04066 | 8/20 | 0.50 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.50 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.50 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.50 |
| ▸ | PIM1 | P11309 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | GBA1 | P04062 | 6/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6278007 | 1.00 | S1PR1 (0.60) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL8580603 | 1.00 | S1PR1 (0.60) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL1931621 | 1.00 | S1PR1 (0.60) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL8580607 | 1.00 | S1PR1 (0.60) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL8580608 | 1.00 | S1PR1 (0.60) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL3433087 | 0.98 | S1PR1 (0.57) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL1517549 | 0.91 | S1PR1 (0.50) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL19373685 | 0.91 | S1PR1 (0.50) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL8890392 | 0.88 | S1PR1 (0.54) | S1PR1S1PR3FUCA1GNAI3GNAO1 | |
| SCHEMBL7609638 | 0.88 | S1PR1 (0.54) | S1PR1S1PR3FUCA1GNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013009372-A1 | PHOSPHORUS-CONTAINING SECONDARY AMINE COMPOUNDS | HUNTSMAN PETROCHEMICAL LLC (US) | 2013-01-17 | — | — | WO | disclosed |
| US-8080626-B2 | Chain extenders | ALBEMARLE CORPORATION (US) | 2011-12-20 | — | — | US | disclosed |
| US-7964695-B2 | Chain extenders | ALBEMARLE CORPORATION (US) | 2011-06-21 | — | — | US | disclosed |
| US-20110137005-A1 | Chain Extenders | ALBEMARLE CORPORATION (US) | 2011-06-09 | — | — | US | disclosed |
| EP-2078048-A1 | DIAMINE CHAIN EXTENDER COMPOSITIONS | Albemarle Corporation (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008039571-A1 | DIAMINE CHAIN EXTENDER COMPOSITIONS | ALBEMARLE CORPORATION (US) | 2008-04-03 | — | — | WO | disclosed |
| US-20070270566-A1 | Chain Extenders | ALBEMARLE CORPORATION (US) | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270566-A1 | Chain Extenders | DDC, PARG, ODC1 | S1PR1 4288/4885S1PR3 3807/4885FUCA1 4412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.